Discover the complete record of transactions filed by Weiser Michael, 董事. Officer active across 1 company, notably Iovance Biotherapeutics, INC.. Cumulatively, 1 disclosures have been logged. Split: 1 buy · 0 sell. Total volume traded: €14k. History available since 31 May 2022. The latest transaction was disclosed on 31 May 2022 (Acquisition). Regulator: SEC (Form 4). All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 条申报中的 1 条
Michael Weiser is a Board Member at Iovance Biotherapeutics, Inc. He brings valuable expertise in biotechnology. His role involves overseeing the company's strategies and ensuring compliance with industry standards. Michael contributes to strategic decision-making that influences innovation and growth at Iovance.